Novavax announced Monday that it has formally submitted a request for the US Food and Drug Administration to authorize its coronavirus vaccine for emergency use in the United States The request is based on data that includes the results of two large clinical trials that demonstrated an overall...
31 business novavax vaccine fda
booster novavax s coronavirus vaccine
country: united states
covid alternative novavax vaccine
fda emergency use authorization
novavax s adjuvant
protein based vaccine platform
smalllaboratorybuiltpieces
stanley erck novavax s president
two large clinical trials
